Crispr Therapeutics shares owned by Mach-1 Financial Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mach-1 Financial Group
from 13F filings
Historical chart of Mach-1 Financial Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Mach-1 Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Mach-1 Financial Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $441k | 7.0k | 62.60 |